Lv1
22 积分 2021-07-19 加入
Determination of a PDE4 Inhibitor Hemay005 in Human Plasma and Urine by UPLC–MS/MS and its Application to a PK Study
2天前
已关闭
Determination of a PDE4 Inhibitor Hemay005 in Human Plasma and Urine by UPLC–MS/MS and its Application to a PK Study
2天前
已关闭
408 Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial
30天前
已完结
408 Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial
1个月前
已完结
Long‐term efficacy and safety of stapokibart for moderate‐to‐severe atopic dermatitis: 52‐week results from a phase 3 trial
1个月前
已完结
Effects of Tralokinumab on Clinical and Laboratory Indexes in Atopic Dermatitis: A 24-Week Real-World Study
1个月前
已完结
24-Week Real-World Effectiveness and Safety of Lebrikizumab for Atopic Dermatitis in Japan: An Analysis Stratified by Prior Systemic Therapy
1个月前
已完结
Effectiveness of Anti‐ IL ‐13 Antibodies on Head and Neck Lesions in Atopic Dermatitis: 48‐Week Outcomes by Lebrikizumab and Tralokinumab
1个月前
已完结
732 - EASI 90 response sustained up to 38 weeks after lebrikizumab withdrawal despite negligible serum concentrations
3个月前
已完结
Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities
3个月前
已完结
皖公网安备34019202002308
